Search research articles
Contact Us
Filters
Showing results (231-240 of 242) with videos related to
Page
of 25
Sort By:
Computational and Structural Biotechnology Journal
|
March 8, 2021
Deciphering extrachromosomal circular DNA in Arabidopsis
Keyi Wang, Hui Tian, Lequn Wang, et al.
Iscience
|
October 10, 2024
Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma
Weipu Mao, Kangjie Xu, Keyi Wang, et al.
Med (New York, N.Y.)
|
August 29, 2025
Anti-PD-1 antibody plus anlotinib vs. anlotinib alone in patients with refractory chondrosarcoma: A multicenter, non-randomized phase 2 FLAIL-C trial
Binghao Li, Lu Xie, Junbo Liang, et al.
Experimental & Molecular Medicine
|
June 18, 2023
piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to hnRNPU and thereby inhibiting MUC12 ubiquitination
Wentao Zhang, Zongtai Zheng, Keyi Wang, et al.
International Journal of Surgery (London, England)
|
April 22, 2022
Can "domino" therapy effectively treat the infection around the prosthesis after the limb salvage surgery of bone tumor? - A study of sequential therapy
Haochen Mou, Hao Qu, Binghao Li, et al.
Cancer Research Communications
|
April 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2024
Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450]
Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2023
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC
Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, et al.
Oncogene
|
August 6, 2025
MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression
Hiroki Ozawa, Yin Wang, Henry G Withers, et al.
Cancer Immunology, Immunotherapy : CII
|
January 21, 2023
Human γδ T cells induce CD8<sup>+</sup> T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK
Shengdong Wang, Hengyuan Li, Tao Chen, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 242) with videos related to
Sort By:
Page
of 25
Computational and Structural Biotechnology Journal
|
March 8, 2021
Deciphering extrachromosomal circular DNA in Arabidopsis
Keyi Wang, Hui Tian, Lequn Wang, et al.
Iscience
|
October 10, 2024
Single-cell RNA sequencing and spatial transcriptomics of bladder Ewing sarcoma
Weipu Mao, Kangjie Xu, Keyi Wang, et al.
Med (New York, N.Y.)
|
August 29, 2025
Anti-PD-1 antibody plus anlotinib vs. anlotinib alone in patients with refractory chondrosarcoma: A multicenter, non-randomized phase 2 FLAIL-C trial
Binghao Li, Lu Xie, Junbo Liang, et al.
Experimental & Molecular Medicine
|
June 18, 2023
piRNA-1742 promotes renal cell carcinoma malignancy by regulating USP8 stability through binding to hnRNPU and thereby inhibiting MUC12 ubiquitination
Wentao Zhang, Zongtai Zheng, Keyi Wang, et al.
International Journal of Surgery (London, England)
|
April 22, 2022
Can "domino" therapy effectively treat the infection around the prosthesis after the limb salvage surgery of bone tumor? - A study of sequential therapy
Haochen Mou, Hao Qu, Binghao Li, et al.
Cancer Research Communications
|
April 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas
Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2024
Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450]
Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 4, 2023
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC
Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, et al.
Oncogene
|
August 6, 2025
MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression
Hiroki Ozawa, Yin Wang, Henry G Withers, et al.
Cancer Immunology, Immunotherapy : CII
|
January 21, 2023
Human γδ T cells induce CD8<sup>+</sup> T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK
Shengdong Wang, Hengyuan Li, Tao Chen, et al.
Page
of 25